id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-351407-7vx9lzi0	Mehta, Puja	JAK inhibitors in COVID-19: need for vigilance regarding increased inherent thrombotic risk	2020-07-06		.txt	text/plain	1249	62	32	recently reported a cohort study of 137 patients with COVID-19 pneumonia, in which retrospective review of computed tomography pulmonary angiography (CTPA) scans demonstrated a cumulative incidence of pulmonary emboli (PE) of 24% overall and 50% in intensive care [2]. We recommend vigilance to the potentially increased thrombotic risk associated with JAKi, given the hypercoagulability of COVID-19 and our recent thromboprophylaxis recommendations for all hospitalised patients with COVID-19 [7]. Bompard et al recently reported a cohort study of 137 patients with COVID-19 pneumonia, in which retrospective review of computed tomography pulmonary angiography (CTPA) scans demonstrated a cumulative incidence of pulmonary emboli (PE) of 24% overall and 50% in intensive care 2 . Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials	./cache/cord-351407-7vx9lzi0.txt	./txt/cord-351407-7vx9lzi0.txt